Skip to main content

AstraZeneca receives $486M in U.S. funding to advance Covid-19 antibody treatment

The therapy is similar to the monoclonal antibody treatment by Regeneron that President Trump received.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.